Yvonne Li

Interim CFO and Treasurer

Ms. Li has been serving as our interim Chief Financial Officer and Treasurer since May 2024. She is a seasoned finance executive with more than 25 years of extensive experience in equity financing, strategic financial planning and analysis, technical accounting, and internal controls. Prior to joining Senti, from 2019 to 2023, she held several roles at Nkarta Therapeutics, a publicly held biopharmaceutical company, including most recently as Chief Administrative Officer. She oversaw Nkarta’s accounting, finance, and associated budgetary and administrative operations, SEC regulatory compliance, and human resources administration. Before that, she was Senior Vice President of Finance at Amunix, a private biotech company acquired by Sanofi. Over her 12-year career at OncoMed Pharmaceuticals, she held senior leadership roles in finance, accounting and operations, including most recently as Principal Financial and Accounting Officer. Her contributions were pivotal in guiding the company through its IPO and a cross-border merger, and she played a key role in major strategic partnership transactions.

Ms. Li is a Certified Public Accountant (inactive) and member of the American Institute of Certified Public Accountants. She earned her BA from the National Taiwan Normal University and MBA from San Francisco State University.